
Urvistat-T Tablet
Marketer
Urvija Pharmaceuticals
Salt Composition
Telmisartan (40mg) + Atorvastatin (10mg)
Overview Urvistat-T Tablet
Combifat-HP is a dual-action medication addressing elevated blood pressure and cholesterol. Reducing blood pressure mitigates the risk of future cardiac events like stroke. Combifat-HP may be administered with or without food, consistently at prescribed intervals for optimal efficacy. Consistent daily timing aids adherence. Treatment duration and dosage are individualized. Complete the prescribed course, regardless of symptom improvement. Lifestyle modifications, including regular exercise, smoking cessation, and a low-sodium, low-fat diet, enhance treatment effectiveness. Common side effects include nausea, abdominal discomfort, constipation, headache, and myalgia. Somnolence and vertigo may occur; avoid driving or activities requiring alertness until effects are known. Report persistent or bothersome side effects to your physician. Potassium-rich foods should be limited. Regular monitoring of blood pressure, glucose, and electrolytes may be necessary. Inform your doctor of kidney or liver disease, or severe dehydration prior to commencing treatment. Pregnant or lactating individuals require prior medical consultation. Disclose all other medications to your healthcare provider due to potential interactions.
Uses of Urvistat-T Tablet
Elevated cholesterol and hypertension
Major Benefits of Urvistat-T Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Urvistat-T Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Urvistat-T Tablet:
- Nausea
- Stomach pain
- Constipation
- Headache
- Dizziness
- Muscle pain
- Weakness
- Increased glucose level in blood
- Increased potassium level in blood
- Increased liver enzymes
How to use Urvistat-T Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Urvistat-T Tablets can be administered with or without food, although consistent timing is recommended.
How Urvistat-T Tablet works:
Telmisartan and Atorvastatin, combined in Urvistat-T tablets, offer effective management of elevated blood pressure and cholesterol levels.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Urvistat-T Tablet is inadvisable.
PregnancyUNSAFE
Employing Urvistat-T tablets during pregnancy presents a substantial risk. Pregnant women should consult their physician; research in animal and human studies indicates significant potential harm to the fetus.
Breast feedingSAFE IF PRESCRIBED
Use of Urvistat-T Tablets while breastfeeding appears to pose minimal risk. Available human data indicates insignificant danger to the infant.
DrivingUNSAFE
Taking Urvistat-T Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Urvistat-T Tablets without requiring a dosage change. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised.
LiverCAUTION
Patients with liver impairment should use Urvistat-T Tablets cautiously, potentially requiring dosage modification under medical supervision. Urvistat-T Tablets are contraindicated in patients experiencing severe or active liver disease.
What if you forget to take Urvistat-T Tablet :
Should you forget a Urvistat-T Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Urvistat-T Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
